ORLANDO, Fla., June 1, 2011 /PRNewswire/ -- GeneLink Biosciences, Inc. (OTCBB: GNLK.OB, "the Company," "GeneLink," or "GeneLink Biosciences"), a leading consumer genomics biotech company, held its Scientific Advisory Board Meeting at Disney's Contemporary Resort Convention Center in Orlando, Florida from May 20-22, 2011. GeneLink Biosciences hosted the three day meeting to focus on the Company's growth strategy and the advances being made in genomics where GeneLink maintains its leadership position. The Company combines genetic science, wellness and customization to create distinctive and innovative consumer products.
The Company plans to launch two exciting new personalized consumer product lines in 2011. These include a large scale direct-to-consumer initiative featuring a new brand being launched with Robert P. Trussell, Jr., Founder and Vice-Chairman of Tempur-Pedic, Inc., and a specialized exclusive product line for aesthetic physicians under GeneLink's Dermagenetics® brand. The product applications include skincare, nutritional supplements and weight management. Clinical trials are anticipated to begin this summer to support and further validate the Company's new and existing product lines.
GeneLink brought together its top scientific experts, its Board of Directors, management team, and leaders of the Company's new marketing and product teams to focus on the Company's evolving expansion and the development of its newest product lines.
Dr. Bernard Kasten, Executive Chairman and CEO, led this unique multi-disciplinary gathering of scientists and business leaders and observed: "The interaction of these leaders is further defining the exciting path forward for the Company. Building on GeneLink's pioneering heritage and expertise in the application of genomic testing to personalized wellness, the Company continues to secure its position as the recognized leader in this rapidly emerging
|SOURCE GeneLink Biosciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved